FDA Approves DAPTACEL® for 5th DTaP dose

In March, the US Food and Drug Administration (FDA) approved the license application for a new Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine (DAPTACEL®). The new vaccine is licensed for use as a fifth dose booster immunization at four to six years of age following four previous doses of DAPTACEL®.  For additional information visit the FDA site, product approval information. http://www.fda.gov/cber/products/daptacel.htm